CHICAGO, IL, USA I April 03, 2025 I Meitheal Pharmaceuticals, Inc. (“Meitheal”), a fully integrated biopharmaceutical company based in Chicago focused on the ...

Eli Lilly (LLY) leads with groundbreaking tirzepatide (Mounjaro/Zepbound), while Hims & Hers Health (HIMS) faces challenges.

For a variety of reasons, Globe Food contributor Kara Baskin took the leap and started Zepbound. But first she worried: "What ...

The trend of prescribing semaglutide to treat cardiovascular disease is expected to continue to grow. At the American College ...

Novo Nordisk will pay $200 million up front, with up to $1.8 billion in additional payments down the line, The Wall Street ...

Weight loss drugs have surged in popularity. But Gov. Ned Lamont wants CT’s Medicaid program to discontinue covering them for ...

Tirzepatide acts on two targets — GLP-1 (glucagon-like peptide-1 ... granted to Eli Lilly for importing and marketing the medicine in a single dose pre-filled pen and in a single-dose vial in June ...

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

Mounjaro is a prescription medicine available as a pre-filled single-dose pen in 2.5 mg, 5 mg ... designed to bind to glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 ...

Ozempic (semaglutide) is a brand-name injection pen used to treat type 2 diabetes ... dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist.

Ozempic belongs to a group of drugs called glucagon-like peptide-1 receptor agonists ... Ozempic is given as a weekly dose. Each pen has several doses. The number of doses per pen will depend ...